Literature DB >> 24176976

Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.

Christopher Gardner1, Roberta Magliozzi, Pascal F Durrenberger, Owain W Howell, Jon Rundle, Richard Reynolds.   

Abstract

A substantial proportion of cases with secondary progressive multiple sclerosis have extensive inflammation in the leptomeninges that is associated with increased subpial demyelination, neuronal loss and an exacerbated disease course. However, the mechanisms underlying this extensive subpial pathology are poorly understood. We hypothesize that pro-inflammatory cytokine production within the meninges may be a key to this process. Post-mortem cerebrospinal fluid and dissected cerebral leptomeningeal tissue from patients with multiple sclerosis were used to study the presence of tumour necrosis factor and interferon gamma protein and messenger RNA levels. A novel model of subpial cortical grey matter demyelination was set up in Dark Agouti rats and analysed using quantitative immunohistochemistry. Increased expression of the pro-inflammatory cytokines tumour necrosis factor and interferon gamma was found in the meninges of cases with secondary progressive multiple sclerosis exhibiting tertiary lymphoid-like structures. Injection of tumour necrosis factor and interferon gamma into the subarachnoid space of female Dark Agouti rats pre-immunized with a subclinical dose of myelin oligodendrocyte glycoprotein mimicked the pathology seen in multiple sclerosis, including infiltration of lymphocytes (CD4+ and CD8+ T cells and CD79+ B cells) into the meninges and extensive subpial demyelination. Extensive microglial/macrophage activation was present in a gradient from the pial surface to deeper cortical layers. Demyelination did not occur in control animals immunized with incomplete Freund's adjuvant and injected with cytokines. These results support the hypothesis that pro-inflammatory molecules produced in the meninges play a major role in cortical demyelination in multiple sclerosis, but also emphasize the involvement of an anti-myelin immune response.

Entities:  

Keywords:  demyelination; immune-mediated demyelination; microglia; multiple sclerosis; neuroinflammation

Mesh:

Substances:

Year:  2013        PMID: 24176976     DOI: 10.1093/brain/awt279

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imaging.

Authors:  Emma Sprooten; Rafael O'Halloran; Juliane Dinse; Won Hee Lee; Dominik Andreas Moser; Gaelle Eve Doucet; Morgan Goodman; Hannah Krinsky; Alejandro Paulino; Alexander Rasgon; Evan Leibu; Priti Balchandani; Matilde Inglese; Sophia Frangou
Journal:  Neuroimage       Date:  2018-10-09       Impact factor: 6.556

2.  No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.

Authors:  Mehrnaz Ighani; Samuel Jonas; Izlem Izbudak; Seongjin Choi; Alfonso Lema-Dopico; Jun Hua; Erin E O'Connor; Daniel M Harrison
Journal:  Mult Scler       Date:  2019-10-01       Impact factor: 6.312

3.  Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.

Authors:  Liqin Yang; Haiqing Li; Wei Xia; Chao Quan; Lei Zhou; Daoying Geng; Yuxin Li
Journal:  Eur Radiol       Date:  2019-11-20       Impact factor: 5.315

4.  Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.

Authors:  Daniel M Harrison; Kevin Y Wang; Julie Fiol; Kerry Naunton; Walter Royal; Jun Hua; Izlem Izbudak
Journal:  J Neuroimaging       Date:  2017-05-02       Impact factor: 2.486

5.  Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation.

Authors:  Mehrnoosh Jafari; Adrian-Minh Schumacher; Nicolas Snaidero; Emily M Ullrich Gavilanes; Tradite Neziraj; Virág Kocsis-Jutka; Daniel Engels; Tanja Jürgens; Ingrid Wagner; Juan Daniel Flórez Weidinger; Stephanie S Schmidt; Eduardo Beltrán; Nellwyn Hagan; Lisa Woodworth; Dimitry Ofengeim; Joseph Gans; Fred Wolf; Mario Kreutzfeldt; Ruben Portugues; Doron Merkler; Thomas Misgeld; Martin Kerschensteiner
Journal:  Nat Neurosci       Date:  2021-01-25       Impact factor: 24.884

6.  Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.

Authors:  Priya Chaudhary; Gail Marracci; Danielle Galipeau; Edvinas Pocius; Brooke Morris; Dennis Bourdette
Journal:  J Neuroimmunol       Date:  2015-11-11       Impact factor: 3.478

7.  Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study II.

Authors:  Priya Palta; Qian-Li Xue; Jennifer A Deal; Linda P Fried; Jeremy D Walston; Michelle C Carlson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-26       Impact factor: 6.053

Review 8.  The meninges: new therapeutic targets for multiple sclerosis.

Authors:  Abigail E Russi; Melissa A Brown
Journal:  Transl Res       Date:  2014-09-01       Impact factor: 7.012

Review 9.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

10.  Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury.

Authors:  Lesley A Ward; Dennis Sw Lee; Anshu Sharma; Angela Wang; Ikbel Naouar; Xianjie I Ma; Natalia Pikor; Barbara Nuesslein-Hildesheim; Valeria Ramaglia; Jennifer L Gommerman
Journal:  JCI Insight       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.